Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Long-Term Debt Repayments (2018 - 2024)

Cytosorbents (CTSO) has disclosed Long-Term Debt Repayments for 3 consecutive years, with $4.4 million as the latest value for Q2 2024.

  • For the quarter ending Q2 2024, Long-Term Debt Repayments changed N/A year-over-year to $4.4 million, compared with a TTM value of $5.0 million through Dec 2024, changed N/A, and an annual FY2024 reading of $5.0 million, changed N/A over the prior year.
  • Long-Term Debt Repayments was $4.4 million for Q2 2024 at Cytosorbents, up from $625000.0 in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $15.0 million in Q4 2020 and bottomed at $625000.0 in Q1 2024.